# FDA Inspection 1021816 - Inga Pharmaceuticals - June 16, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/inga-pharmaceuticals/5c91376d-2dae-45bb-8e4a-4c65456b86a7
Source feed: FDA_Inspections

> FDA Inspection 1021816 for Inga Pharmaceuticals on June 16, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1021816
- Company Name: Inga Pharmaceuticals
- Inspection Date: 2017-06-16
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1253404 - 2024-09-06](https://www.globalkeysolutions.net/records/fda_inspections/inga-pharmaceuticals/4981d3ed-da52-419f-877d-3f118a7c9677)
- [FDA Inspection 1253404 - 2024-09-06](https://www.globalkeysolutions.net/records/fda_inspections/inga-pharmaceuticals/881e992c-d505-402e-9d57-73ac0fea9222)

Company: https://www.globalkeysolutions.net/companies/inga-pharmaceuticals/26709dfe-6819-4571-9361-b48f9e814a1d

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c